A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

NCT06377228 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision (no safety concerns)

Conditions

Refractory Lupus Nephritis
Refractory Systemic Sclerosis

Interventions

BIOLOGICAL: TAK-007
DRUG: Chemotherapy Agents

Sponsor

Takeda